Zhang, F.; Han, L.; Wang, B.; Huang, Q.; Yawalkar, N.; Zhang, Z.; Yan, K.
Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis. J. Clin. Med. 2022, 11, 7059.
https://doi.org/10.3390/jcm11237059
AMA Style
Zhang F, Han L, Wang B, Huang Q, Yawalkar N, Zhang Z, Yan K.
Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis. Journal of Clinical Medicine. 2022; 11(23):7059.
https://doi.org/10.3390/jcm11237059
Chicago/Turabian Style
Zhang, Fuxin, Ling Han, Bing Wang, Qiong Huang, Nikhil Yawalkar, Zhenghua Zhang, and Kexiang Yan.
2022. "Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis" Journal of Clinical Medicine 11, no. 23: 7059.
https://doi.org/10.3390/jcm11237059
APA Style
Zhang, F., Han, L., Wang, B., Huang, Q., Yawalkar, N., Zhang, Z., & Yan, K.
(2022). Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis. Journal of Clinical Medicine, 11(23), 7059.
https://doi.org/10.3390/jcm11237059
